Project 3 is designed to probe the neurobiological underpinnings of age-related cognitive decline in female rhesus monkeys as well as the capacity of various unopposed estrogen treatments (ET) and/or combined hormone treatments (HT) to sustain a neuronal and synaptic phenotype that preserves cognitive function. We are particulariy interested in the synaptic characteristics of excitatory circuits in dorsolateral prefrontal cortex (dIPFC) and hippocampus that are predictive of cognitive performance and/or differentially affected by age and ET or HTs with high clinical relevance. We will also reveal the synaptic repercussions of altering the time of onset and duration of treatment following ovariectomy (OVX) and how these synaptic indices relate to the cognitive effects of delaying or terminated treatment. These studies will impact our knowledge of synaptic and molecular links to cognitive performance and age-related cognitive decline as well as the effects of multiple variations in the design and timing of ET/HT on key synaptic indices, providing new potential therapeutic targets and strategies to sustain optimal synaptic and cognitive health. Synaptic indices are obtained through quantitative neuronal reconstruction, confocal analyses, and postembedding immunogold electron microscopy (EM), and correlated with cognitive performance through regression analyses.
Specific Aim 1 will use archival tissue from young and aged ovariectomized (OVX) female rhesus monkeys that received vehicle or cyclical ET to determine the key molecular attributes of the axospinous synapses that are vulnerable to aging and responsive to ET, and which synaptic characteristics predict sustained cognitive performance seen in aged monkeys with this ET regimen. Key molecular targets will be NMDA and AMPA glutamate receptors, synaptic estrogen receptors (e.g., ERa, ERp, and GPR30), and signaling molecules linked to spinogenesis that emerge from Project 1 and have been analyzed in the rat model (e.g., PELP1).
Specific Aim 2 will use similar approaches to define the spine and synaptic effects of HT regimens that employ cyclical or chronic E with and without cyclical or chronic progesterone (P) to determine how these regimens compare to cyclical unopposed E.
Specific Aim 3 will determine whether or not there is a """"""""window of opportunity"""""""" for beneficial synaptic effects of ET/HT after cessation of ovarian function, and how long the beneficial effects endure without continued treatment. In all cases, we will study the brains of animals at the conclusion of cognitive testing. These results will provide critically important information for the design of HTs that provide maximal neurological benefits for post-menopausal women.

Public Health Relevance

This project is designed to reveal the interactive effects of age and estrogen on the brain circuits that mediate cognition. The proposed experiments will provide a conceptual and neurobiological framework for the design of more effective hormone treatments for menopausal women than those that are currently in use.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG016765-14
Application #
8645553
Study Section
Special Emphasis Panel (ZAG1-ZIJ-9)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
14
Fiscal Year
2014
Total Cost
$306,993
Indirect Cost
$125,046
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
McEwen, Bruce S; Milner, Teresa A (2017) Understanding the broad influence of sex hormones and sex differences in the brain. J Neurosci Res 95:24-39
Nutsch, Victoria L; Will, Ryan G; Tobiansky, Daniel J et al. (2017) Age-related changes in sexual function and steroid-hormone receptors in the medial preoptic area of male rats. Horm Behav 96:4-12
Nutsch, Victoria L; Bell, Margaret R; Will, Ryan G et al. (2017) Aging and estradiol effects on gene expression in the medial preoptic area, bed nucleus of the stria terminalis, and posterodorsal medial amygdala of male rats. Mol Cell Endocrinol 442:153-164
Marques-Lopes, Jose; Tesfaye, Ephrath; Israilov, Sigal et al. (2017) Redistribution of NMDA Receptors in Estrogen-Receptor-?-Containing Paraventricular Hypothalamic Neurons following Slow-Pressor Angiotensin II Hypertension in Female Mice with Accelerated Ovarian Failure. Neuroendocrinology 104:239-256
Garcia, Alexandra N; Bezner, Kelsey; Depena, Christina et al. (2017) The effects of long-term estradiol treatment on social behavior and gene expression in adult female rats. Horm Behav 87:145-154
Almey, Anne; Milner, Teresa A; Brake, Wayne G (2016) Estrogen receptor ? and G-protein coupled estrogen receptor 1 are localized to GABAergic neurons in the dorsal striatum. Neurosci Lett 622:118-23
Mazid, Sanoara; Hall, Baila S; Odell, Shannon C et al. (2016) Sex differences in subcellular distribution of delta opioid receptors in the rat hippocampus in response to acute and chronic stress. Neurobiol Stress 5:37-53
Naugle, Michelle M; Lozano, Sateria A; Guarraci, Fay A et al. (2016) Age and Long-Term Hormone Treatment Effects on the Ultrastructural Morphology of the Median Eminence of Female Rhesus Macaques. Neuroendocrinology 103:650-64
Garcia, Alexandra N; Depena, Christina K; Yin, Weiling et al. (2016) Testing the critical window of estradiol replacement on gene expression of vasopressin, oxytocin, and their receptors, in the hypothalamus of aging female rats. Mol Cell Endocrinol 419:102-12
Marques-Lopes, Jose; Lynch, Mary-Katherine; Van Kempen, Tracey A et al. (2015) Female protection from slow-pressor effects of angiotensin II involves prevention of ROS production independent of NMDA receptor trafficking in hypothalamic neurons expressing angiotensin 1A receptors. Synapse 69:148-65

Showing the most recent 10 out of 125 publications